Control of mammary tumor differentiation by SKI-606 (bosutinib).
about
An update on dual Src/Abl inhibitors.Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.Promising molecular targeted therapies in breast cancermiR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis.Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.Targeting EZH2 for cancer therapy: progress and perspective.Spontaneous tumour regression in keratoacanthomas is driven by Wnt/retinoic acid signalling cross-talk.Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.Modeling human liver cancer heterogeneity: virally induced transgenic models and mouse genetic models of chronic liver inflammation.SRC increases MYC mRNA expression in ER+ breast cancer via mRNA stabilization and inhibition of p53 function.Developmental Stage-Specific Embryonic Induction of HepG2 Cell Differentiation.
P2860
Q34270677-58109AA9-359B-40A4-AD16-B645074405D9Q35000624-B1A8668A-D278-4A82-9828-1A6A908ECADFQ35040295-2D3A0C36-D3AD-4C16-9412-2D65C776BC48Q35207623-C6958F6C-0373-4581-B1C1-D55A5B89A547Q35665700-342C9CC3-382D-4415-9A83-145FB11B9038Q35779175-33E12720-7CE4-4A76-B714-C84B0E6896CCQ36140620-A23545C5-E66E-4BCD-BAC7-036481B01E0BQ37204063-5A8C4EB6-6B01-440C-A688-673F0086C9F9Q37682007-DA019952-984D-4378-ACDE-9552CEB8101AQ39160945-AF82DE87-3C77-4989-A411-D2BAEBF6930CQ41636479-381CB40B-E071-470B-B682-A7B955D85FE5Q47230860-DEA5560E-7377-49F9-81F6-F2598B281712Q50544520-ADD5DFC1-20F9-42E5-A6E6-79EBDD2792F1
P2860
Control of mammary tumor differentiation by SKI-606 (bosutinib).
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Control of mammary tumor differentiation by SKI-606 (bosutinib).
@ast
Control of mammary tumor differentiation by SKI-606 (bosutinib).
@en
Control of mammary tumor differentiation by SKI-606
@nl
type
label
Control of mammary tumor differentiation by SKI-606 (bosutinib).
@ast
Control of mammary tumor differentiation by SKI-606 (bosutinib).
@en
Control of mammary tumor differentiation by SKI-606
@nl
prefLabel
Control of mammary tumor differentiation by SKI-606 (bosutinib).
@ast
Control of mammary tumor differentiation by SKI-606 (bosutinib).
@en
Control of mammary tumor differentiation by SKI-606
@nl
P2093
P2860
P356
P1433
P1476
Control of mammary tumor differentiation by SKI-606 (bosutinib).
@en
P2093
A Charbono
E Rosfjord
F Boschelli
L G Ellies
P2860
P2888
P304
P356
10.1038/ONC.2010.412
P407
P577
2010-09-06T00:00:00Z
P5875
P6179
1010962161